Health Reporter of Georgia
SEE OTHER BRANDS

Fresh news on health and wellness in the state of Georgia

Health Reporter of Georgia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Reporter of Georgia.

Press releases published on May 7, 2025

PreemploymentDirectory.com Publishes its Sixteenth Suppliers to the Background Screening Industry Buyers’ Guide

PreemploymentDirectory.com Publishes its Sixteenth Suppliers to the Background Screening Industry Buyers’ Guide

We are extremely pleased to be able to showcase many of the top suppliers to background screening providers in the world in our annual suppliers buyer’s guide. ACWORTH, GA, UNITED STATES, May 7, 2025 /⁨EINPresswire.com⁩/ -- This is the sixteenth edition …

 Art Pharmacy Partners with Wellstar Health System for Innovative Health and Wellness Program

Art Pharmacy Partners with Wellstar Health System for Innovative Health and Wellness Program

Novel arts-based health program helps improve overall wellbeing ATLANTA, GA, UNITED STATES, May 7, 2025 /⁨EINPresswire.com⁩/ -- Art Pharmacy, which connects people to arts and culture events to support health and well-being, is partnering with Wellstar …

J-Type Supra-(Carbon Dots) for Near-Infrared Light-Triggered Pyroptosis

J-Type Supra-(Carbon Dots) for Near-Infrared Light-Triggered Pyroptosis

GA, UNITED STATES, May 7, 2025 /⁨EINPresswire.com⁩/ -- Deep-penetration light-triggered pyroptosis based on nanomedicine for tumor precision therapy still remains challenging. Towards this goal, Scientist in China reported a supramolecular engineering …

DLH Reports Fiscal 2025 Second Quarter Results

DLH Reports Fiscal 2025 Second Quarter Results

ATLANTA, May 07, 2025 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of science research and development, systems engineering and integration, and digital transformation and cyber security solutions to …

Alzamend Neuro Partners with QMENTA, to Advance AI-Powered Imaging for its Phase II Clinical Trial of AL001 Study to Take Place at Massachusetts General Hospital

Alzamend Neuro Partners with QMENTA, to Advance AI-Powered Imaging for its Phase II Clinical Trial of AL001 Study to Take Place at Massachusetts General Hospital

Head-to-head studies of AL001 versus a marketed lithium carbonate product will be conducted for comparisons of lithium blood and brain/brain-structure pharmacokinetics in healthy subjects ATLANTA, May 07, 2025 (GLOBE NEWSWIRE) -- Alzamend Neuro, Inc. ( …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service